Keybanc Rates Hinge Health (HNGE) buy, $90 Price Target
Keybanc has reiterated its buy rating on Hinge Health, Inc. with a price target of $90, while the stock trades at $67.81, a 32.72% upside from the current price.
Reviewed by automated data checks against the source data. How we make and check alerts
Keybanc rated Hinge Health, Inc. ($HNGE) "buy" with a $90 price target on June 12, 2026.
Since the rating, $HNGE is up 5.4% after 1 week, up 37.7% after 1 month and up 51.8% to date (from the $65.34 close on Jun 12, 2026).
HNGE
Hinge Health, Inc.
Key Points
- Keybanc reiterated its buy rating on Hinge Health, Inc. (HNGE) on June 12, 2026, setting a price target of $90.
- The stock is currently priced at $67.81, significantly below the target, indicating potential upside for investors.
- Hinge Health focuses on automating care delivery for musculoskeletal issues, serving self-insured employers.
Get $HNGE trade alerts by text
We text you when insiders, Congress or big funds trade $HNGE. Free.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Hinge Health, Inc. alert may contain errors. Disclosures
Keybanc's Buy Rating on Hinge Health
On June 12, 2026, Keybanc reiterated its buy rating on Hinge Health, Inc. (HNGE) with a price target of $90. The stock is currently trading at $67.81, which shows a notable difference from the target price, suggesting possible growth ahead.
Analysts Set New Price Targets
Keybanc's Scott Schoenhaus expressed confidence in Hinge Health's potential, maintaining the buy rating. This comes as the company is positioned in the healthcare sector, focusing on the delivery of care for musculoskeletal issues. The stock's current price is well below the target, which may attract investor interest. Other firms have also maintained positive ratings, including Needham, which set a target of $115, and Barclays, which has a target of $110. This collective outlook emphasizes the potential for Hinge Health to perform well in the market.
Recent Insider Activity
Hinge Health has seen recent insider activity from LLC Insight Holdings Group. On June 25, 2026, the group bought 530,982 shares. They also purchased 1,466,667 shares on June 29, 2026. However, on the same day, they sold another 1,466,667 shares at an average price of $82.84, totaling about $121.5 million in value. This trading activity reflects ongoing interest in the company's stock.
What Hinge Health, Inc. Does
Hinge Health, Inc. is based in San Francisco, California, and specializes in automating care delivery for musculoskeletal issues. The company uses technology to provide personalized care through AI-powered motion tracking and wearable devices, primarily serving self-insured employers. This focus on innovative healthcare solutions is critical as the company continues to grow in a competitive market.
What’s Next for Hinge Health
Investors will be looking forward to Hinge Health's next earnings report set for November 2, 2026. As a reminder, the recent analyst ratings reflect the company's past performance and may change as new data emerges. Keybanc's reiteration of its buy rating and price target indicates ongoing confidence in Hinge Health's growth trajectory.
$HNGE price target
Hinge Health, Inc. daily closes and this analyst's $90 target. Not advice.
Related Filing Alerts
Source: Keybanc's rating change on $HNGE (Jun 12, 2026). Written by software, not financial advice. How we make alerts